Literature DB >> 6372032

Epidemiology of Clostridium difficile-induced intestinal disease.

M E Mulligan.   

Abstract

The epidemiology of Clostridium difficile-induced intestinal disease is an intriguing subject about which there are few answers but many remaining questions. Although it is accepted that altered intestinal microecology (usually the result of antimicrobial therapy) is a major predisposition to disease, the details of microbial interactions are not yet known and clearly involve more than simple overgrowth of a resistant member of the resident flora. A variety of reservoirs of C. difficile are recognized. These include endogenous carriage, environmental contamination, and zoonoses, but the relative epidemiologic importance of these varied sources is yet to be determined. Because minor variations in methods for cultivation of C. difficile can markedly affect the ability to detect the organism, even the prevalence of endogenous carriage by various populations is not fully defined. There is good evidence for nosocomial acquisition of disease, but the frequency of this event and the usefulness of preventive measures need to be determined. The development of a typing system would provide a valuable tool for investigating many of the remaining questions. Finally, in addition to the recognized risk factors, which include the apparently predisposing alteration in intestinal microecology and exposure to C. difficile, there appear to be other, as yet undefined, variables that help to determine whether disease will occur. Perhaps the elucidation of the details of the pertinent microbial interactions as well as an understanding of the relevant host-pathogen relationships will provide important insights into the epidemiology of C. difficile-induced disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372032     DOI: 10.1093/clinids/6.supplement_1.s222

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

1.  Bacterial chromosomal restriction endonuclease analysis of the homology of Bacteroides species.

Authors:  W C Bradbury; R G Murray; C Mancini; V L Morris
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

Review 2.  Genomic approaches to studying the human microbiota.

Authors:  George M Weinstock
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

3.  Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis.

Authors:  Charat Thongprayoon; Wisit Kaewput; Spencer T Hatch; Tarun Bathini; Konika Sharma; Karn Wijarnpreecha; Patompong Ungprasert; Matthew D'Costa; Michael A Mao; Wisit Cheungpasitporn
Journal:  Dig Dis Sci       Date:  2018-08-11       Impact factor: 3.199

4.  Computer-aided densitometric analysis of protein patterns of Clostridium difficile.

Authors:  W Ehret; M Turba; P Pfaller; W Heizmann; G Ruckdeschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

5.  Incidence and significance of Clostridium difficile in hospitalized cancer patients.

Authors:  M Gérard; N Defresne; D Daneau; P Van der Auwera; M Delmée; A M Bourguignon; F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

Review 6.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 7.  Antibiotic therapy in aging patients.

Authors:  S R Norrby
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

8.  Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; C Kajzer; N Planas; J C Petit
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics.

Authors:  T V Riley; J E Adams; G L O'Neill; R A Bowman
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

10.  Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.

Authors:  M A Schleupner; D C Garner; K M Sosnowski; C J Schleupner; L J Barrett; E Silva; D Hirsch; R L Guerrant
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.